Brain recovering with regular use of PEMF therapy.
Multiple Sclerosis (MS)
Multiple sclerosis (MS) causes demyelination of both the brain and spinal cord. Because the entire nervous system revolves around the function of both these organs, MS can result in a wide array of symptoms. Not all people affected by MS will experience the same symptoms. Some forms of MS are more severe than others, but everyone who suffers from it will feel a compromise in their quality of life. Some of the symptoms of MS include: changes in sensation (hypoesthesia), muscle weakness, abnormal muscle spasms, or difficulty moving; difficulties with coordination and balance; problems in speech (dysarthria) or swallowing (dysphagia), visual problems (nystagmus, optic neuritis, phosphenes or diplopia), fatigue and acute or chronic pain syndromes, bladder and bowel difficulties, cognitive impairment, or emotional symptomatology (mainly major depression). There is no known cause of MS and no real cure either. Treatment revolves around various drug therapies to manage symptoms. However, many of these drug therapies aren’t effective and come with potentially hazardous side effects.
PEMF and Multiple Sclerosis
Traditional therapy aims at treating the symptoms of MS, usually after an episodic attack or flare-up. PEMF’s can help treat symptoms, but also prevent them from even occurring. By enhancing neurotransmitter function, PEMF’s can help diminish many of the effects of MS. One study showed a 55-year-old woman with a 5-year history of chronic progressive multiple sclerosis (MS) in whom a single external application of extremely low magnetic fields (MF) resulted in a rapid improvement in symptoms including vision, cerebellar symptomatology (ataxia and dysarthria), bladder functions, mood, sleep, cognitive functions and fatigue. Improvement in the patient’s symptoms was associated with normalization of the pretreatment abnormal visual evoked potential (VEP) latencies within 24 hours after magnetic treatment. This is a very positive development for patients with MS.
(R. Sandyk, “Rapid Normalization of Visual Evoked Potentials picoTesla Range Magnetic Fields in Chronic Progressive Multiple Sclerosis,” International Journal of Neurosci, 77(3-4), August 1994, p. 243-259.)